Editorial: Role of Inflammation in Neurodegenerative Diseases

1 Department of Neurosurgery, Maxine Dunitz Neurosurgical Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States, 2 Department of Biomedical Sciences, Division of Applied Cell Biology and Physiology, Cedars-Sinai Medical Center, Los Angeles, CA, United States, 3 Geriatric Research Education and Clinical Center, Veterans Greater Los Angeles HealthCare System, Los Angeles, CA, United States, 4 Department of Neurology, University of California, Los Angeles, Los Angeles, CA, United States, 5 Department of Medicine, University of California, Los Angeles, Los Angeles, CA, United States, 6 Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, United States

[1]  K. Black,et al.  Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation , 2022, Cells.

[2]  B. Gaire Microglia as the Critical Regulators of Neuroprotection and Functional Recovery in Cerebral Ischemia , 2021, Cellular and Molecular Neurobiology.

[3]  Miles C. Miller,et al.  Meningeal B Cell Clusters Correlate with Submeningeal Pathology in a Natural Model of Multiple Sclerosis , 2021, The Journal of Immunology.

[4]  P. Shah,et al.  Parallels between retinal and brain pathology and response to immunotherapy in old, late‐stage Alzheimer's disease mouse models , 2020, Aging cell.

[5]  G. Münch,et al.  In search of an anti-inflammatory drug for Alzheimer disease , 2020, Nature Reviews Neurology.

[6]  D. Teplow,et al.  Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease. , 2019, Brain : a journal of neurology.

[7]  K. Black,et al.  Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes , 2017, Cellular and Molecular Life Sciences.

[8]  M. Schwartz,et al.  Neurological Disease as a Failure of Brain-Immune Crosstalk: The Multiple Faces of Neuroinflammation. , 2016, Trends in immunology.

[9]  J. I. Alvarez,et al.  Glial-endothelial crosstalk regulates blood-brain barrier function. , 2016, Current opinion in pharmacology.

[10]  M. Schwartz,et al.  Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer's disease pathology , 2015, Nature Communications.

[11]  Keith L Black,et al.  Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease. , 2015, Brain : a journal of neurology.

[12]  O. Garaschuk,et al.  Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.

[13]  M. Schwartz,et al.  The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus , 2014, The EMBO journal.

[14]  K. Szekeres,et al.  Trafficking CD11b-Positive Blood Cells Deliver Therapeutic Genes to the Brain of Amyloid-Depositing Transgenic Mice , 2010, The Journal of Neuroscience.

[15]  Michal Schwartz,et al.  Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Julien,et al.  Innate immunity: the missing link in neuroprotection and neurodegeneration? , 2002, Nature Reviews Neuroscience.